OREXO AB SP/ADR (ORXOY) analyst actions
Rating and price-target actions on ORXOY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ORXOY overview →
1 measured ORXOY analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Orexo initiates new study of OX640 in participants with allergic rhinitis | Press release | +0.00% | +0.00% |
Keep exploring
More ORXOY: earnings → · SEC filings → · ORXOY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Spectral Medical Inc (EDT_TSE) | 63 | 0.00% | 38% |
| Infinity Pharmaceuticals, Inc. (INFI) | 63 | +3.96% | 71% |
| Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) | 62 | 0.00% | 40% |
| LIFT & CO CORP (LIFT_CDNX) | 62 | -0.52% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.